Dendritic cells (DCs) are professional antigen-presenting cells contributing to regulation of lymphocyte immune response. DCs are divided into two subtypes: CD11c-positive conventional or myeloid (cDCs) and CD123-positive plasmacytoid (pDCs) DCs. The aim of the study was to assess DCs (HLA-DR+ lineage-) and their subtypes by flow cytometry in peripheral blood and subcutaneous (SAT) and epicardial (EAT) adipose tissue in subjects with (T2DM, n = 12) and without (non-T2DM, n = 17) type 2 diabetes mellitus undergoing elective cardiac surgery. Subjects with T2DM had higher fasting glycemia (8.6 ± 0.7 vs. 5.8 ± 0.2 mmol/l, p < 0.001) and glycated hemoglobin (52.0 ± 3.4 vs. 36.9 ± 1.0 mmol/mol, p < 0.001) and tended to have more pronounced inflammation (hsCRP: 9.8 ± 3.1 vs. 5.1 ± 1.9 mg/ml, p = 0.177) compared with subjects without T2DM. T2DM was associated with reduced total DCs in SAT (1.57 ± 0.65 vs. 4.45 ± 1.56% for T2DM vs. non-T2DM, p = 0.041) with a similar, albeit insignificant, trend in EAT (0.996 ± 0.33 vs. 2.46 ± 0.78% for T2DM vs. non-T2DM, p = 0.171). When analyzing DC subsets, no difference in cDCs was seen between any of the studied groups or adipose tissue pools. In contrast, pDCs were increased in both SAT (13.5 ± 2.0 vs. 4.6 ± 1.9% of DC cells, p = 0.005) and EAT (29.1 ± 8.7 vs. 8.4 ± 2.4% of DC, p = 0.045) of T2DM relative to non-T2DM subjects as well as in EAT of the T2DM group compared with corresponding SAT (29.1 ± 8.7 vs. 13.5 ± 2.0% of DC, p = 0.020). Neither obesity nor coronary artery disease (CAD) significantly influenced the number of total, cDC, or pDC in SAT or EAT according to multiple regression analysis. In summary, T2DM decreased the amount of total dendritic cells in subcutaneous adipose tissue and increased plasmacytoid dendritic cells in subcutaneous and even more in epicardial adipose tissue. These findings suggest a potential role of pDCs in the development of T2DM-associated adipose tissue low-grade inflammation.

2nd Department of Surgery Department of Cardiovascular Surgery Charles University and General University Hospital Prague Czech Republic

Anesthesiology Department Cardiac Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Cardiovascular Surgery Department Cardiac Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Centre for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Anaesthesiology Resuscitation and Intensive Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Diabetes Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

See more in PubMed

Collin M., Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3–20. doi: 10.1111/imm.12888. PubMed DOI PMC

Sundara Rajan S., Longhi M. P. Dendritic cells and adipose tissue. Immunology. 2016;149(4):353–361. doi: 10.1111/imm.12653. PubMed DOI PMC

Cools N., Ponsaerts P., van Tendeloo V. F. I., Berneman Z. N. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. Journal of Leukocyte Biology. 2007;82(6):1365–1374. doi: 10.1189/jlb.0307166. PubMed DOI

Tamura T., Tailor P., Yamaoka K., et al. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. Journal of Immunology. 2005;174(5):2573–2581. doi: 10.4049/jimmunol.174.5.2573. PubMed DOI

Gilliet M., Cao W., Liu Y. J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nature Reviews Immunology. 2008;8(8):594–606. doi: 10.1038/nri2358. PubMed DOI

Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annual Review of Immunology. 2013;31(1):563–604. doi: 10.1146/annurev-immunol-020711-074950. PubMed DOI PMC

Chung C. Y. J., Ysebaert D., Berneman Z. N., Cools N. Dendritic cells: cellular mediators for immunological tolerance. Clinical & Developmental Immunology. 2013;2013, article 972865:8. doi: 10.1155/2013/972865. PubMed DOI PMC

Murdolo G., Smith U. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutrition, Metabolism, and Cardiovascular Diseases. 2006;16(Supplement 1):S35–S38. doi: 10.1016/j.numecd.2005.10.016. PubMed DOI

Macdougall C. E., Wood E. G., Loschko J., et al. Visceral adipose tissue immune homeostasis is regulated by the crosstalk between adipocytes and dendritic cell subsets. Cell Metabolism. 2018;27(3):588–601.e4. doi: 10.1016/j.cmet.2018.02.007. PubMed DOI PMC

Bertola A., Ciucci T., Rousseau D., et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247. doi: 10.2337/db11-1274. PubMed DOI PMC

Chen Y., Tian J., Tian X., et al. Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PLoS One. 2014;9(3, article e92450) doi: 10.1371/journal.pone.0092450. PubMed DOI PMC

Stefanovic-Racic M., Yang X., Turner M. S., et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes. 2012;61(9):2330–2339. doi: 10.2337/db11-1523. PubMed DOI PMC

Cho K. W., Zamarron B. F., Muir L. A., et al. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance. Journal of Immunology. 2016;197(9):3650–3661. doi: 10.4049/jimmunol.1600820. PubMed DOI PMC

Salazar J., Luzardo E., Mejías J. C., et al. Epicardial fat: physiological, pathological, and therapeutic implications. Cardiology Research and Practice. 2016;2016:15. doi: 10.1155/2016/1291537.1291537 PubMed DOI PMC

Horckmans M., Bianchini M., Santovito D., et al. Pericardial adipose tissue regulates granulopoiesis, fibrosis, and cardiac function after myocardial infarction. Circulation. 2018;137(9):948–960. doi: 10.1161/CIRCULATIONAHA.117.028833. PubMed DOI

Ghosh A. R., Bhattacharya R., Bhattacharya S., et al. Adipose recruitment and activation of plasmacytoid dendritic cells fuel metaflammation. Diabetes. 2016;65(11):3440–3452. doi: 10.2337/db16-0331. PubMed DOI

Hannibal T. D., Schmidt-Christensen A., Nilsson J., Fransén-Pettersson N., Hansen L., Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60(10):2033–2041. doi: 10.1007/s00125-017-4341-0. PubMed DOI PMC

Henrichot E., Juge-Aubry C. E., Pernin A.`., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(12):2594–2599. doi: 10.1161/01.ATV.0000188508.40052.35. PubMed DOI

Iacobellis G., Corradi D., Sharma A. M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nature Clinical Practice Cardiovascular Medicine. 2005;2(10):536–543. doi: 10.1038/ncpcardio0319. PubMed DOI

Hirata Y., Kurobe H., Akaike M., et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. International Heart Journal. 2011;52(3):139–142. doi: 10.1536/ihj.52.139. PubMed DOI

McAninch E. A., Fonseca T. L., Poggioli R., et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity. 2015;23(6):1267–1278. doi: 10.1002/oby.21059. PubMed DOI PMC

Vianello E., Dozio E., Arnaboldi F., et al. Epicardial adipocyte hypertrophy: association with M1-polarization and toll-like receptor pathways in coronary artery disease patients. Nutrition, Metabolism, and Cardiovascular Diseases. 2016;26(3):246–253. doi: 10.1016/j.numecd.2015.12.005. PubMed DOI

Mazurek T., Zhang L. F., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–2466. doi: 10.1161/01.CIR.0000099542.57313.C5. PubMed DOI

Qiu T., Li M., Tanner M. A., et al. Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic mice. Metabolism. 2018;85:76–89. doi: 10.1016/j.metabol.2018.03.002. PubMed DOI PMC

Koivisto V. A., Pelkonen R., Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 1989;38(5):641–647. doi: 10.2337/diab.38.5.641. PubMed DOI

Braun D., Caramalho I., Demengeot J. IFN-α/β enhances BCR-dependent B cell responses. International Immunology. 2002;14(4):411–419. doi: 10.1093/intimm/14.4.411. PubMed DOI

Bratke K., Klein C., Kuepper M., Lommatzsch M., Virchow J. C. Differential development of plasmacytoid dendritic cells in Th1- and Th2-like cytokine milieus. Allergy. 2011;66(3):386–395. doi: 10.1111/j.1398-9995.2010.02497.x. PubMed DOI

Alsharifi M., Lobigs M., Regner M., Lee E., Koskinen A., Mullbacher A. Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. Journal of Immunology. 2005;175(7):4635–4640. doi: 10.4049/jimmunol.175.7.4635. PubMed DOI

Camarena V., Sant D., Mohseni M., et al. Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue. Nutrition, Metabolism and Cardiovascular Diseases. 2017;27(8):739–750. doi: 10.1016/j.numecd.2017.05.010. PubMed DOI PMC

Gaborit B., Venteclef N., Ancel P., et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovascular Research. 2015;108(1):62–73. doi: 10.1093/cvr/cvv208. PubMed DOI